FETOMATERNAL MEDICINE
FRIDAY, NOVEMBER 25

08:30-10:00

A PREIS SCHOOL ACADEMY SESSION

HALL C

 

10:00-10:20 Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50

HOT CONTROVERSIES

HALL C
Capsule
Chairpersons TBA
Debate: cfDNA testing
For Universal cfDNA testing by genome wide approach: Mireille Bekker, Netherlands
Against genome wide cfDNA testing: TBA
Discussion
Stem cells in obstetrics and gynecology
Wolfgang Holzgreve¸Germany
Fetal surgery: Learning curve
Luc JoyeuxBelgium
  TTTS +/- sFGR: long-term effects
Jeanine van Klink, Netherlands
Treatment of Rh disease
Joanne VerweijNetherlands

 

11:50-12:00 Break

 

12:00-13:30 HYPERTENSIVE DISORDERS HALL C
Capsule Hypertensive disorders are associated with underlying placental and maternal changes, and are associated with endothelial dysfunction and vasospasm, leading to placental insufficiency and serious consequences for the mother and infant.
Chairpersons Gerard Visser, Netherlands
What is new and controversial In Hypertension in pregnancy?
Asma Khalil, UK
The SNAP-HT trial: optimal postpartum BP control
Paul Leeson, UK
Does birth cure preeclampsia?
Basky Thilaganathan, UK
New treatments to prevent complications
Yariv Yogev, Israel

 

13:30-14:30  Lunch break,  moderated e-posters and visit the exhibition Exhibition Area

 

14:30-16:30 AN ARTIFICIAL WOMB FOR EXTREMELY PRETERM INFANTS HALL C
Capsule
Chairpersons Guid Oei, Netherlands
Mats BrännströmSweden
An artificial womb for extremely preterm infants
Guid Oei, Netherlands
Development of a liquid-based incubator for extremely premature infants
Mark Schöberer, Germany
Ethical aspects of the development of a liquid based incubator
Joanne Verweij, Netherlands
MATERNAL VACCINATION
Capsule
Chairpersons Kitty Bloemenkamp, Netherlands
Mireille Bekker, Netherlands
Efficacy and safety of available maternal vaccinations: Update on available literature (syst review)
Odette de Bruin, Netherlands
Emily Phijffer, Netherlands
Maternal vaccinations: EMA’s perspective
Corinne de Vries, Netherlands
Maternal vaccinations: Patients perspective (Infant protection through maternal immunization, why do women accept or don’t accept maternal vaccinations
Flor M. Munoz, USA
Panel Discussion

 

16:30-16:50  Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 GDM AND PRE-GDM HALL C
Capsule
Chairpersons
Debate: All women with GDM should be induced at 38 weeks?
Pro: Nir Melamed, Canada own expense
Con: TBA
Discussion
How to define well glycemic control
Yariv Yogev, Israel  
What is the best pharmacological therapy for GDM? (Metformin\glyburide\insulin?)
Yariv Yogev, Israel
GDM in twins – More harm than a disease?
TBA
Progmatic approach for GDM diagnosis
Eran Ashwal, Canada